Airain Ltd’s Exponent EXPO Stock Holding History

Airain Ltd’s Portfolio EXPO Stock Details EXPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-9,270	Closed	-$276K	–	900
2017 Q1	$276K	Buy	+9,270	New	+$270K	0.01%	643

Other funds holding EXPO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Airain Ltd's EXPO Position: Q2 2017 in Review

Airain Ltd sold out of Exponent (EXPO) in Q2 2017, closing a stake of 9,270 shares — an estimated $276K sold.

Airain Ltd first reported a position in EXPO in Q1 2017 and held it in 1 quarter. The position peaked at $276K in Q1 2017. 185 funds tracked by Wall St. Rank hold EXPO as of Q2 2017.

Airain Ltd reported no remaining Exponent position as of Q2 2017 after selling out during the quarter.
Airain Ltd sold 9,270 Exponent shares in Q2 2017, an estimated $276K.
Airain Ltd first reported a position in Exponent in Q1 2017 and held it in 1 quarter.
Airain Ltd's Exponent position peaked at $276K in Q1 2017.
185 funds tracked by Wall St. Rank held Exponent as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.